Meta-analysis of genetic polymorphisms in programmed cell death 1: Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility;Metaanalyse von Genpolymorphismen beim programmierten Zelltod 1: Assoziationen mit der Suzeptibiliät für rheumatoide Arthritis, ankylosierende Spondylitis und Typ-1-Diabetes

Zeitschrift fur Rheumatologie

Volumn 74, Issue 3, 2015, Pages 230-239

  Lee, Y H ^a   Bae, S C ^b   Kim, J H ^a   Song, G G ^a  

^a Korea University College of Medicine   (South Korea)

^b Hanyang University Medical Center   (South Korea)

Author keywords

Apoptosis; Autoimmune diseases; Gene frequency; Inflammation; Peripheral tolerance

Indexed keywords

GENETIC MARKER; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ANKYLOSING SPONDYLITIS; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; COMORBIDITY; DIABETES MELLITUS, TYPE 1; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; META ANALYSIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGRAMMED CELL DEATH 1 RECEPTOR; SPONDYLITIS, ANKYLOSING;

EID: 84939892080     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-014-1415-y     Document Type: Article

References (36)

1. Lee YH, Rho YH, Choi SJ et al (2005) Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50:453–459
2. Choi SJ, Rho YH, Ji JD et al (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166–170
3. Lee YH, Rho YH, Choi SJ et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 46:49–56
4. Okazaki T, Wang J (2005) PD-1/PD-L pathway and autoimmunity. Autoimmunity 38:353–357
5. Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10:1563–1572
6. Prokunina L, Castillejo-Lopez C, Oberg F et al (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666–669
7. Tahoori MT, Pourfathollah AA, Akhlaghi M et al (2011) Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clin Exp Rheumatol 29:763–767
8. Iwamoto T, Ikari K, Inoue E et al (2007) Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet 52:557–560
9. Kong EK, Prokunina-Olsson L, Wong WH et al (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52:1058–1062
10. Prokunina L, Padyukov L, Bennet A et al (2004) Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 50:1770–1773
11. Yang Q, Liu Y, Liu D et al (2011) Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population. Clin Exp Rheumatol 29:13–18
12. Soleimanifar N, Amirzargar AA, Mahmoudi M et al (2011) Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation 34:707–712
13. Liu X, Hu LH, Li YR et al (2011) Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int 31:209–213
14. Lee SH, Lee YA, Woo DH et al (2006) Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 8:R163
15. Flores S, Beems M, Oyarzun A et al (2010) Programmed cell death 1 (PDCD1) gene polymorphisms and type 1 diabetes in Chilean children. Rev Med Chil 138:543–550
16. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D et al (2010) Association of the CYP27B1C(-1260)A polymorphism with autoimmune Addison’s disease. Exp Clin Endocrinol Diabetes 118:544–549
17. Momin S, Flores S, Angel BB et al (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 83:289–294
18. Cooper JD, Smyth DJ, Bailey R et al (2007) The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet 8:71
19. Hiromine Y, Ikegami H, Fujisawa T et al (2007) Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus. Metabolism 56:905–909
20. Ni R, Ihara K, Miyako K et al (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum Genet 121:223–232
21. Nielsen C, Hansen D, Husby S et al (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62:492–497
22. Asad S, Nikamo P, Torn C et al (2007) No evidence of association of the PDCD1 gene with Type 1 diabetes. Diabet Med 24:1473–1477
23. Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118:225–234
24. Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371
25. Song GG, Bae SC, Lee YH (2012) Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 31:1733–1739
26. Davey Smith G, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182
27. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
28. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
29. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
30. Lee YH, Woo JH, Choi SJ et al (2009) Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 18:9–15
31. Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: why and where it occurs. Nat Med 7:899–905
32. Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62:309–317
33. Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 18:230–243
34. Kang BR, Kim H, Nam SH et al (2012) CopA3 peptide from Copris tripartitus induces apoptosis in human leukemia cells via a caspase-independent pathway. BMB Rep 45:85–90
35. Hiromine Y, Ikegami H, Fujisawa T et al (2006) Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility. Ann N Y Acad Sci 1079:285–288
36. Mori M, Yamada R, Kobayashi K et al (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264–266